棒傑股份(002634.SZ):終止發行股份購買綠瘦健康產業集團100%股權
格隆匯5月29日丨棒傑股份(002634.SZ)公佈,公司因籌劃以發行股份的方式向優創投資有限公司、皮濤濤購買其合計持有的綠瘦健康產業集團有限公司100%股權,根據深圳證券交易所的相關規定,經公司申請,公司股票自2020年5月18日開市時起開始停牌。
截至公告日,由於交易各方未能在規定時間內就此次重大資產重組的核心條款達成一致,經審慎考慮,公司決定終止籌劃此次發行股份購買資產事項。
經向深圳證券交易所申請,公司股票將於2020年6月1日開市時起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.